135 related articles for article (PubMed ID: 7947268)
1. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia.
Goulden N; Langlands K; Steward C; Katz F; Potter M; Chessells J; Oakhill A
Br J Haematol; 1994 Jun; 87(2):282-5. PubMed ID: 7947268
[TBL] [Abstract][Full Text] [Related]
2. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
[TBL] [Abstract][Full Text] [Related]
3. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.
Potter MN; Steward CG; Oakhill A
Br J Haematol; 1993 Mar; 83(3):412-8. PubMed ID: 8485046
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse.
Lal A; Kwan E; al Mahr M; Zhou L; Ferrara D; Tobias V; O'Gorman Hughes D; Haber M; Norris MD; Marshall GM
Mol Pathol; 1998 Oct; 51(5):277-81. PubMed ID: 10193523
[TBL] [Abstract][Full Text] [Related]
5. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia.
Steward CG; Goulden NJ; Katz F; Baines D; Martin PG; Langlands K; Potter MN; Chessells JM; Oakhill A
Blood; 1994 Mar; 83(5):1355-62. PubMed ID: 8118037
[TBL] [Abstract][Full Text] [Related]
6. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia.
O'Reilly J; Meyer B; Baker D; Herrmann R; Cannell P; Davies J
Leukemia; 1995 Apr; 9(4):624-7. PubMed ID: 7723395
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
[TBL] [Abstract][Full Text] [Related]
8. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
9. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
[TBL] [Abstract][Full Text] [Related]
10. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
[TBL] [Abstract][Full Text] [Related]
11. Study of minimal residual disease in B-cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes.
Botsonis T; Tsangaris GT; Mikraki V; Tzortzatou-Stathopoulou F
Anticancer Res; 1999; 19(3B):2211-20. PubMed ID: 10472333
[TBL] [Abstract][Full Text] [Related]
12. Polymerase chain reaction-single-strand conformational polymorphism analysis of antigen receptor rearrangements in monitoring therapeutic effect in childhood ALL.
Thunberg U; Sällström J; Frost BM; Lönnerholm G; Sundström C
Diagn Mol Pathol; 1998 Jun; 7(3):146-51. PubMed ID: 9836069
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of detecting minimal residual disease in the bone marrow of patients with B-cell neoplasm].
Yu L; Sun Y; Liu J
Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):22-5. PubMed ID: 7600873
[TBL] [Abstract][Full Text] [Related]
14. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract][Full Text] [Related]
15. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
[TBL] [Abstract][Full Text] [Related]
16. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction.
Potter MN; Steward CG; Maitland NJ; Oakhill A
Leukemia; 1992 Apr; 6(4):289-94. PubMed ID: 1588791
[TBL] [Abstract][Full Text] [Related]
17. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse.
Jacquy C; Delepaut B; Van Daele S; Vaerman JL; Zenebergh A; Brichard B; Vermylen C; Cornu G; Martiat P
Br J Haematol; 1997 Jul; 98(1):140-6. PubMed ID: 9233577
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome.
Nizet Y; Martiat P; Vaerman JL; Philippe M; Wildmann C; Staelens JP; Cornu G; Ferrant A; Michaux JL; Sokal G
Br J Haematol; 1991 Oct; 79(2):205-10. PubMed ID: 1958477
[TBL] [Abstract][Full Text] [Related]
20. Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia.
Ito Y; Wasserman R; Galili N; Reichard BA; Shane S; Lange B; Rovera G
J Clin Oncol; 1993 Mar; 11(3):546-53. PubMed ID: 8445430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]